US › Healthcare

Lunai Bioworks Inc. (LNAI)

US · Healthcare · Biotechnology

$2.27+4.84%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

$20,942

Net profit

$-2.6M

Profit YoY

-1459.3%

EPS

$-0.10

Net margin

-12,278.6%

Key statistics

Market cap

$9.8M

Forward P/E

0.0

P/B

0.48

Book value

$-2.14

EPS (TTM)

$-63.14

52-week high

$15.36

52-week low

$1.21

50-day MA

$2.42

200-day MA

$4.09

Beta

0.34

Shareholding

Insiders

40.72%

Institutions

3.53%

Largest institutional holders

Fund	Stake
Ground Swell Capital, LLC	1.17%
Geode Capital Management, LLC	0.50%
BlackRock Inc	0.35%
Nine Masts Capital Limited	0.28%
Citigroup Inc	0.28%
Vanguard Capital Management, LLC	0.27%
Virtu Financial LLC	0.21%
Vanguard Fiduciary Trust Co	0.19%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Lunai Bioworks Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.